FrancophonIA/ELRC3.0 huggingface dataset:
English: Docetaxel Zentiva in combination with androgen-deprivation therapy (ADT), with or without prednisone or prednisolone, is indicated for the treatment of patients with metastatic hormonesensitive prostate cancer.
Danish: Docetaxel Zentiva i kombination med androgen deprivationsbehandling, med eller uden prednison eller prednisolon, er indiceret til behandling af patienter med metastatisk hormonfølsom prostatakræft.
English: • Induction chemotherapy followed by radiotherapy (TAX 323) MedDRA system organ classes
Danish: • Induktionskemoterapi efterfulgt af strålebehandling (TAX 323) Systemorganklasser i henhold til MedDRAdatabasen
English: Patients with baseline neutrophil count of < 1,500 cells/mm3.
Danish: Patienter med en udgangsværdi for neutrofile værdier på < 1.500 celler/mm
English: In this study, 255 patients were randomised to treatment with docetaxel (75 mg/m2 as a 1 hour intravenous infusion every 3 weeks) and capecitabine (1250 mg/m2 twice daily for 2 weeks followed by 1-week rest period).
Danish: I dette kliniske studium randomiseredes 255 patienter til behandling med docetaxel (75 mg/m² som en 1-times intravenøs infusion hver 3. uge) og capecitabin (1250 mg/m to gange daglig i 2 uger efterfulgt af en uges pause).
English: Patients should not be retreated with subsequent cycles of docetaxel until neutrophils recover to a level > 1,500 cells/mm3 and platelets recover to a level > 100,000 cells/mm3.
Danish: Patienter bør ikke genbehandles med efterfølgende cyklusser af docetaxel indtil neutrofil-antallet gendannes til et niveau  1.500 celler/mm og blodplader gendannes til et niveau
English: LIST OF EXCIPIENTS Excipients: polysorbate 80, ethanol anhydrous (see leaflet for further information) and citric acid.
Danish: Hjælpestoffer: Polysorbat 80, vandfri ethanol (læs indlægssedlen for yderligere information) og citronsyre.
English: After 10 years of follow up in study TAX316, acute leukaemia was reported in 3 of 744 TAC patients (0.4%) and in 1 of 736 FAC patients (0.1%).
Danish: Efter 10 års opfølgning i TAX 316 studiet blev akut leukæmi rapporteret hos 3 ud af 744 TACpatienter (0,4 %) og hos 1 ud af 736 FAC-patienter (0,1 %).
English: The most commonly reported adverse reactions of docetaxel alone are: neutropenia (which was reversible and not cumulative; the median day to nadir was 7 days and the median duration of severe neutropenia (< 500 cells/mm3) was 7 days), anaemia, alopecia, nausea, vomiting, stomatitis, diarrhoea and asthenia.
Danish: De mest almindeligt rapporterede bivirkninger med docetaxel var: Neutropeni (som var reversibel og ikke kumulativ, median-dagen til nadir var 7 dage og median-varigheden af alvorlig neutropeni ( 500 celler/mm
English: Docetaxel Zentiva is an antineoplastic agent and, as with other potentially toxic compounds, caution should be exercised when handling it and preparing Docetaxel Zentiva solutions.
Danish: Docetaxel Zentiva er et antineoplastisk stof, og ligesom andre potentielle toksiske stoffer skal det behandles med forsigtighed ved håndtering og tilberedning af Docetaxel Zentiva-opløsningerne.
English: SPECIAL STORAGE CONDITIONS Do not store above 25°C.
Danish: Må ikke opbevares ved temperaturer over 25 ºC.
English: - For the treatment of prostate cancer, Docetaxel Zentiva is administered in combination with prednisone or prednisolone.
Danish: • Ved behandling af prostatakræft kan Docetaxel Zentiva indgives i kombination med prednison eller prednisolon.
English: The required volume of Docetaxel Zentiva concentrate for solution for infusion must be injected via a single injection (one shot) into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Danish: Den nødvendige mængde Docetaxel Zentiva koncentrat til infusionsvæske, opløsning, skal via en enkelt injektion (et skud) injiceres i en 250 ml infusionspose eller -flaske indeholdende enten en 5 % glucoseinfusionsvæske eller en 0,9 % natriumchloridinfusionsvæske.
English: 2 years
Danish: måneder.
English: Docetaxel Zentiva in combination with cisplatin and 5-fluorouracil is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck.
Danish: Docetaxel Zentiva i kombination med cisplatin og 5-fluoruracil er indiceret til indledende behandling af patienter med inoperable, lokale, fremskredne skællede celle-carcinoma i hoved og hals.
English: If Docetaxel Zentiva concentrate or infusion solution should come into contact with skin, wash immediately and thoroughly with soap and water.
Danish: Hvis Docetaxel Zentiva infusionskoncentrat eller infusionsvæske skulle komme på huden, så vask omgående og grundigt med sæbe og vand.
English: Oral candidiasis Hypocalcaemia (G3: 0%) Hypophosphataemia (G3-4: 1%) Hypokalaemia (G3: 0%)
Danish: Feber (G3: 1%) Oral candidiasis Hypokalcæmi (G3: 0%) Hypofosfatæmi (G3-4: 1%) Hypokaliæmi (G3: 0%)
English: - For the treatment of lung cancer, Docetaxel Zentiva could be administered either alone or in combination with cisplatin.
Danish: • Ved behandling af lungekræft kan Docetaxel Zentiva enten indgives alene eller i kombination med cisplatin.
English: Docetaxel Zentiva in combination with cisplatin and 5-fluorouracil is indicated for the treatment of patients with metastatic gastric adenocarcinoma, including adenocarcinoma of the gastroesophageal junction, who have not received prior chemotherapy for metastatic disease.
Danish: Docetaxel Zentiva i kombination med cisplatin og 5-fluoruracil er indiceret til behandling af patienter med metastatisk gastrisk adenokarcinom, inklusive adenokarcinom i den gastrooesophageale forbindelse, som ikke tidligere har fået kemoterapi mod metastatisk sygdom.
English: A total of 445 patients with KPS > 70 were treated with either docetaxel (T) (75 mg/m2 on day 1) in combination with cisplatin (C) (75 mg/m2 on day 1) and 5-fluorouracil (F) (750 mg/m2 per day for 5 days) or cisplatin (100 mg/m2 on day 1) and 5-fluorouracil (1000 mg/m2 per day for 5 days).
Danish: 445 patienter med KPS  70 blev behandlet med enten docetaxel (T) (75 mg/m2 på dag 1) i kombination med cisplatin (C) (75 mg/m på dag 1) og 5-fluoruracil (F) (750 mg/m pr. dag i 5 dage)
English: Alopecia (G3: 3%)a Nail changes (G3: 1%)
Danish: Alopeci (G3: 3%) Negleforandringer (G3: 1%)
English: • Docetaxel 30 mg/m2 administered weekly for the first 5 weeks in a 6 week cycle for 5 cycles.
Danish: • Docetaxel 30 mg/m administreret ugentlig i de første 5 uger i en 6 ugers behandlingsrunde i 5
English: In the case of severe neutropenia (< 500 cells/mm3 for seven days or more) during a course of docetaxel therapy, a reduction in dose for subsequent courses of therapy or the use of appropriate symptomatic measures are recommended (see section 4.2).
Danish: 3) i mere end 7 dage i løbet af en docetaxelbehandling, anbefales det at reducere dosis i de efterfølgende cyklusser eller at tage passende symptomatiske forholdsregler (se pkt.
English: • Mitoxantrone 12 mg/m2 every 3 weeks for 10 cycles.
Danish: • Mitoxantrone 12 mg/m hver 3. uge i 10 behandlingsrunder.
English: - If you get any side effects, talk to your doctor, hospital pharmacist or nurse.
Danish: Hvis du oplever bivirkninger, bør du tale med din læge, sygeplejerske eller apoteket.
English: - For the treatment of early breast cancer with or without lymph node involvement, Docetaxel Zentiva could be administered in combination with doxorubicin and cyclophosphamide.
Danish: • Ved behandling af tidlig brystkræft med eller uden lymfeknuder, kan Docetaxel Zentiva anvendes i kombination med doxorubicin eller cyclophosphamid.
English: If Docetaxel Zentiva concentrate or infusion solution should come into contact with mucous membranes, wash immediately and thoroughly with water.
Danish: Hvis Docetaxel Zentiva infusionskoncentrat eller infusionsvæske skulle komme i kontakt med slimhinderne, så vask omgående og grundigt med vand.
English: Docetaxel Zentiva in combination with doxorubicin and cyclophosphamide: adjuvant therapy
Danish: Docetaxel Zentiva i kombination med doxorubicin og cyclophosphamid: Adjuverende behandling
English: Docetaxel Zentiva in combination with doxorubicin
Danish: Docetaxel Zentiva i kombination med doxorubicin
English: • Standard of care + docetaxel 75 mg/m², administered every 3 weeks for 6 cycles
Danish: • Standarpleje + docetaxel 75 mg/m², administreret hver 3. uge i 6 perioder
English: The European Medicines Agency has waived the obligation to submit the results of studies with Docetaxel Zentiva in all subsets of the paediatric population in breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med Docetaxel Zentiva i alle undergrupper af den pædiatriske population ved brystkræft, ikkesmåcellet lungekræft, prostatakræft, gastrisk adenokarcinom og hoved- og halskræft med undtagelse af type II og type III lavt differentieret nasofaryngealt karcinom (se pkt.
English: The incidence of Grade 4 neutropenia, febrile neutropenia and neutropenic infection was decreased in patients who received primary G-CSF prophylaxis (see section 4.8).
Danish: Hyppigheden af grad 4 neutropeni, febril neutropeni og neutropenisk infektion blev reduceret hos patienter der fik primær G-CSF-profylakse (se pkt.
English: In combination with capecitabine, the recommended dose of docetaxel is 75 mg/m2 every three weeks, combined with capecitabine at 1250 mg/m2 twice daily (within 30 minutes after a meal) for 2 weeks followed by a 1-week rest period.
Danish: I kombination med capecitabin er den anbefalede Docetaxel Zentiva-dosis 75 mg/m2 hver 3. uge kombineret med capecitabin 1250 mg/m to gange daglig (indenfor 30 minutter efter et måltid) i 2 uger efterfulgt af en uges pause.
English: Docetaxel Zentiva in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration-resistant prostate cancer.
Danish: Docetaxel Zentiva i kombination med prednison eller prednisolon er indiceret til behandling af patienter med metastatisk kastrationsresistent prostatakræft.
English: Patients on the docetaxel arm received docetaxel (T) 75 mg/m2 followed by cisplatin (P) 75 mg/m2 followed by 5-fluorouracil (F) 750 mg/m2 per day as a continuous infusion for 5 days.
Danish: Patienter i docetaxel-armen fik docetaxel (T) 75 mg/m efterfulgt af cisplatin (P) 75 mg/m efterfulgt af 5-fluoruracil 750 mg/m daglig som en kontinuerlig infusion i 5 dage.
English: • Induction chemotherapy followed by radiotherapy (TAX323) The safety and efficacy of docetaxel in the induction treatment of patients with squamous cell carcinoma of the head and neck (SCCHN) was evaluated in a phase III, multi-centre, open-label, randomised study (TAX323).
Danish: • Induktions kemoterapi efterfulgt af strålebehandling (TAX 323) Sikkerheden og effekten af docetaxel i den indledende behandling af patienter med pladecellecarcinom i hovedet og halsen (SCCHN) blev evalueret i et fase III, multicenter, åbent, randomiseret studie (TAX323).
English: Cautions for use in castration-resistant prostate cancer Of the 333 patients treated with docetaxel every three weeks in a prostate cancer study (TAX 327), 209 patients were 65 years of age or greater and 68 patients were older than 75 years.
Danish: Forsigtighedsregler ved behandling af kastrationsresistent prostatakræft Ud af 333 patienter behandlet med docetaxel hver tredje uge i et prostatakræftstudium (TAX 327), var 209 patienter 65 år eller derover og 68 patienter var ældre end 75 år.
English: As with all parenteral products, Docetaxel Zentiva infusion solution should be visually inspected prior to use, solutions containing a precipitate should be discarded.
Danish: Som ved alle andre parenterale lægemidler skal Docetaxel Zentiva infusionsvæske kontrolleres visuelt for uklarheder, og opløsninger med udfældning skal kasseres.
English: In this study, AT arm showed a higher incidence of severe neutropenia (90% versus 68.6%), febrile neutropenia (33.3% versus 10%), infection (8% versus 2.4%), diarrhoea (7.5% versus 1.4%), asthenia (8.5% versus 2.4%), and pain (2.8% versus 0%) than AC arm. On the other hand, AC arm showed a higher incidence of severe anaemia (15.8% versus 8.5%) than AT arm, and, in addition, a higher incidence of severe cardiac toxicity: congestive heart failure (3.8% versus 2.8%), absolute LVEF decrease  20% (13.1% versus 6.1%), absolute LVEF decrease  30% (6.2% versus 1.1%).
Danish: I dette studie viste AT-armen en hyppigere forekomst af alvorlig neutropeni (90 % versus 68,6 %), febril neutropeni (33,3 % versus 10 %), infektion (8 % versus 2,4 %), diarré (7,5 % versus 1,4 %), asteni (8,5 % versus 2,4 %) og smerter ((2,4 % versus 0 %) end AC-armen.
English: Cases of cutaneous lupus erythematosus, bullous eruptions such as erythema multiforme and severe cutaneous adverse reactions such as Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN) and Acute Generalized Exanthematous Pustulosis (AGEP) have been reported with docetaxel.
Danish: Med docetaxel er der rapporteret tilfælde af kutan lupus erythematosus, bulløst udslæt såsom erythema multiforme og alvorlige kutane bivirkninger såsom Stevens-Johnson syndrom, toksisk epidermal nekrolyse og akut generaliseret eksantematøs pustulose.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 20 April 2007
Danish: Dato for første markedsføringstilladelse: 20. april 2007 Dato for seneste fornyelse: 20. april 2012
English: Consequently, because of the potential for adverse reactions in nursing infants, breast-feeding must be discontinued for the duration of docetaxel therapy.
Danish: På grund af risiko for skadelige påvirkninger af barnet skal amning derfor ophøre under behandling med docetaxel.
English: Docetaxel Zentiva in combination with capecitabine
Danish: Docetaxel Zentiva i kombination med capecitabin
English: Manufacturer(s) Sanofi-Aventis Deutschland GmbH Industriepark Höchst
Danish: Sanofi-Aventis Deutschland GmbH
English: Peripheral sensory neuropathy (≥G3: 2%)a
Danish: Perifer sensorisk neuropati (≥G3: 2%)
English: To be taken into account in pregnant or breast-feeding women, in children and high-risk groups such as patients with liver disease, or epilepsy.
Danish: Der skal tages hensyn hertil ved behandling af gravide og ammende kvinder, børn samt patienter i højrisikogrupper såsom patienter med leversygdom, eller epilepsi.
English: In GEICAM 9805 study peripheral sensory neuropathy that started during the treatment period persisted into the follow-up period in 10 patients (1.9%) in TAC arm and 4 patients (0.8 %) in FAC arm. At the end of the follow-up period (median follow-up time of 10 years and 5 months), peripheral sensory neuropathy was observed to be ongoing in 3 patients (0.6%) in TAC arm, and in 1 patient (0.2%) in FAC arm.
Danish: I studiet GEICAM 9805 forekom perifer sensorisk neuropati under behandlingen og fortsatte ind i opfølgningsperioden hos 10 patienter (1,9 %) i TAC-armen og 4 patienter (0,8 %) i FACarmen.Ved afslutningen af opfølgningsperioden (median opfølgningstid på 10 år og 5 måneder) blev det observeret, at perifer sensorisk neuropati fortsatte hos 3 patienter (0,6 %) i TAC-armen og hos 1 patient (0,2 %) i FAC-armen.
English: Tabulated list of adverse reactions in high-risk locally advanced or metastatic hormone-sensitive prostate cancer for DOCETAXEL 75 mg/m² in combination with prednisone or prednisolone and ADT (STAMPEDE study)
Danish: Tabel over bivirkninger i højrisiko lokalt avanceret eller metastatisk hormonfølsom prostatakræft med DOCETAXEL 75 mg/m² i kombination med prednison eller prednisolon og androgen deprivationsbehandling (STAMPEDE studie).
English: - For the treatment of metastatic gastric cancer, Docetaxel Zentiva is administered in combination with cisplatin and 5-fluorouracil.
Danish: • Ved behandling af metastatisk gastrisk kræft indgives Docetaxel Zentiva i kombination med cisplatin og 5-fluoruracil.
English: In the adjuvant treatment of operable node-positive and node-negative breast cancer, the recommended dose of docetaxel is 75 mg/m2 administered 1-hour after doxorubicin 50 mg/m2 and cyclophosphamide 500 mg/m2 every 3 weeks for 6 cycles (TAC regimen) (see also Dose adjustments during treatment).
Danish: Den anbefalede doxetaxel-dosis til adjuverende behandling af operabel lymfeknude-positiv og lymfeknude-negativ brystkræft er 75 mg/m hver 3. uge i 6 perioder, administreret 1 time efter doxorubicin 50 mg/m2 og cyclophosphamid 500 mg/m2 (TAC-regime) (se også: Dosisjustering under behandling).
English: Based on pharmacokinetic data with docetaxel at 100 mg/m² as single agent, patients who have both elevations of transaminase (ALT and/or AST) greater than 1.5 times the upper limit of the normal range (ULN) and alkaline phosphatase greater than 2.5 times the ULN, the recommended dose of docetaxel is 75 mg/m2 (see sections 4.4 and 5.2).
Danish: På basis af farmakokinetiske data med docetaxel givet som enkeltstof ved en dosis på 100 mg/m2, er den anbefalede dosis docetaxel 75 mg/m til patienter, som både har forhøjelse af transaminase (ALAT og/eller ASAT) på mere end 1,5 gange den øvre normalværdi og af basisk fosfatase på mere end 2,5 gange den øvre normalværdi ( se pkt.
English: Other medicines and Docetaxel Zentiva
Danish: Brug af anden medicin sammen med Docetaxel Zentiva
English: MARKETING AUTHORISATION NUMBER EU/1/07/384/003
Danish: EU/1/07/384/003
English: Each vial of concentrate contains 0.5 ml of ethanol anhydrous (395 mg).
Danish: Hjælpestoffer som behandleren skal være opmærksom på: Hvert hætteglas med koncentrat indeholder 0,5 ml ethanol, vandfri (395 mg).
English: MARKETING AUTHORISATION NUMBER EU/1/07/384/004
Danish: EU/1/07/384/004
English: Note that this is likely to be an underestimate since docetaxel alone at a dose of 100 mg/m2 is known to result in neutropenia in 97% of patients, 76% grade 4, based on nadir blood counts.
Danish: Bemærk, at dette sandsynligvis er underestimeret, da docetaxel alene ved en dosis på 100 mg/m er kendt for at resultere i neutropeni hos
English: Docetaxel Zentiva has been prescribed by your doctor for the treatment of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric cancer or head and neck cancer: - For the treatment of advanced breast cancer, Docetaxel Zentiva could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.
Danish: Docetaxel Zentiva er ordineret af din læge til behandling af bryst- eller specielle former for lungekræft (ikke-småcellet lungekræft), prostata kræft, gastrisk kræft eller hoved- og hals-kræft:
English: MARKETING AUTHORISATION NUMBER EU/1/07/384/005
Danish: EU/1/07/384/005
English: 95% CI p-valuea a p-value calculated from the likelihood ratio test and adjusted for all stratification factors (except center and planned hormone therapy) and stratified by trial period b Failure-free survival: time from randomization to first evidence of at least one of: biochemical failure (defined as a rise in PSA of 50% above the within-24-week nadir and above 4 ng/mL and confirmed by retest or treatment); progression either locally, in lymph nodes, or in distant metastases; skeletal-related event; or death from prostate cancer.
Danish: Fejlfri overlevelse: tiden fra randomiseringen til første bevis for mindst et af: biokemisk svigt (defineret som en stigning i PSA på 50 % over inden-24-ugers nadir og over 4 ng/ml og bekræftet ved omtest eller behandling); progression enten lokalt, i lymfeknuder eller i fjerne metastaser, skeletrelateret begivenhed; eller død af prostatakræft.
English: 95% CI p-valuea
Danish: 95 %CI p-værdi
English: Infection associated with G4 neutropenia
Danish: Infektion associeret med G4-neutropeni (G3/4:
English: How to use Docetaxel Zentiva
Danish: Sådan skal du bruge Docetaxel Zentiva
English: Docetaxel Zentiva 160 mg/8 ml concentrate for solution for infusion requires NO prior dilution with a solvent and is ready to add to the infusion solution.
Danish: Docetaxel Zentiva 160 mg/8 ml koncentrat til infusionsvæske, opløsning kræver INGEN forudgående fortynding med en solvens, men er klar til tilsætning til infusionsvæske.
English: • Induction chemotherapy followed by chemoradiotherapy (TAX 324) For the induction treatment of patients with locally advanced (technically unresectable, low probability of surgical cure, and aiming at organ preservation) squamous cell carcinoma of the head and neck (SCCHN), the recommended dose of docetaxel is 75 mg/m2 as a 1 hour intravenous infusion on day 1, followed by cisplatin 100 mg/m2 administered as a 30-minute to 3-hour infusion, followed by 5-fluorouracil 1000 mg/m2/day as a continuous infusion from day 1 to day 4.
Danish: • Induktions kemoterapi efterfulgt af kemo-stråleterapi (TAX 324) Til den indledende behandling af patienter med lokalt fremskreden pladecellecarcinom i hoved og hals (SCCHN) (ikke muligt af resektere, lav sandsynlighed for kirurgisk helbredelse samt med bevarelse af organer som mål), er den anbefalede dosis docetaxel 75 mg/m som en 1-times intravenøs infusion på dag 1, efterfulgt af cisplatin 100 mg/m administreret som en 30 minutter til 3 timers infusion, efterfulgt af 5-fluoruracil 1000 mg/m som en kontinuerlig infusion fra dag 1 til dag 4.
English: • Then, inject via a single injection (one shot) into a 250 ml infusion bag or bottle containing either 5% glucose solution or sodium chloride 9 mg/ml (0.9%) solution for infusion.
Danish: • Injicer via en enkelt injektion (et stik) den nødvendige mængde Docetaxel Zentiva koncentrat til infusionsvæske, opløsning i en 250 ml infusionspose eller -flaske indeholdende enten en 5 % glucoseinfusionsvæske eller en 0,9 % natriumchloridinfusionsvæske.
English: Median overall survival (months)
Danish: Total overlevelse (Primær endepunkt) Median overlevelsestid (måneder)
English: 102 37 Prague 10
Danish: U kabelovny 130 102 37 Prague 10
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of concentrate contains 20 mg docetaxel (as trihydrate).
Danish: Hver ml koncentrat indeholder 20 mg docetaxel (som trihydrat).
English: - For the treatment of head and neck cancer, Docetaxel Zentiva is administered in combination with cisplatin and 5-fluorouracil.
Danish: • Til behandling af hoved- og hals-kræft indgives Docetaxel Zentiva i kombination med cisplatin og 5-fluoruracil.
English: Docetaxel Zentiva 20 mg/1 ml concentrate for solution for infusion requires NO prior dilution with a solvent and is ready to add to the infusion solution.
Danish: Docetaxel Zentiva 20 mg/1 ml koncentrat til infusionsvæske, opløsning kræver INGEN forudgående fortynding med en solvens, men er klar til tilsætning til infusionsvæske.
English: Aseptically withdraw the required amount of Docetaxel Zentiva concentrate for solution for infusion using a calibrated syringe fitted with a 21G needle.
Danish: Udtag aseptisk den ønskede mængde af Docetaxel Zentiva koncentrat til infusionsvæske, opløsning, med en kalibreret sprøjte påsat en 21G-kanyle.
English: Docetaxel Zentiva 80 mg/4 ml concentrate for solution for infusion requires NO prior dilution with a solvent and is ready to add to the infusion solution.
Danish: Docetaxel Zentiva 80 mg/4 ml koncentrat til infusionsvæske, opløsning kræver INGEN forudgående fortynding med en solvens, men er klar til tilsætning til infusionsvæske.
English: Each vial of concentrate contains 2 ml of ethanol anhydrous (1.58 g).
Danish: Hjælpestoffer som behandleren skal være opmærksom på: Hvert hætteglas med koncentrat indeholder 2 ml ethanol, vandfri (1,58 g).
English: What Docetaxel Zentiva is and what it is used for What you need to know before you use Docetaxel Zentiva How to use Docetaxel Zentiva Possible side effects
Danish: Det skal du vide, før du begynder at bruge Docetaxel Zentiva Sådan skal du bruge Docetaxel Zentiva Bivirkninger